Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Breast Ductal Carcinoma In Situ
- Invasive Breast Carcinoma
- Multicentric Breast Carcinoma
- Multifocal Breast Carcinoma
- Synchronous Bilateral Breast Carcinoma
Interventions
- DRUG: Anastrozole
- DRUG: Exemestane
- OTHER: Laboratory Biomarker Analysis
- DRUG: Letrozole
- OTHER: Quality-of-Life Assessment
- DRUG: Systemic Chemotherapy
- DRUG: Tamoxifen Citrate
Sponsor
National Cancer Institute (NCI)